Upcoming System Maintenance

Notice: Promega will be performing essential system updates January 21–25.

Order processing and shipping will pause starting January 21 at 4:00 PM CST and resume on January 26.
Please plan to order in advance for any products needed during this timeframe.

Please contact Customer Service with any questions.

ApoLive-Glo™ Multiplex Assay Technical Manual

Instructions for Use of Product(s)
G6410, G6411

Literature # TM325

The ApoLive-Glo™ Multiplex Assay combines two assay chemistries to assess viability and caspase activation events within a single assay well. The first part of the assay measures the activity of a protease marker of cell viability. The live-cell protease activity is restricted to intact viable cells and is measured using a fluorogenic, cell-permeant, peptide substrate (glycyl-phenylalanyl-amino fluorocoumarin; GF-AFC). The substrate enters intact cells, where it is cleaved by the live-cell protease activity to generate a fluorescent signal proportional to the number of living cells (Figure 1). This live-cell protease becomes inactive upon loss of cell membrane integrity and leakage into the surrounding culture medium. The second part of the assay uses the Caspase-Glo™ Assay technology to detect caspase-3/7 activation, which is a key biomarker of apoptosis. The assay allows you to measure viability and apoptosis in the same sample well.

Summary of Changes, 3/15 Revision
The following change was made to the 3/15 version of this document:
Patent information and related products sections were updated.

Printed in USA. Revised 3/15.

Experienced User Protocols